Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300442
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,804
Award facts
- Contract value 50% obligated
-
- $3,804.00 Current, with exercised options
- $7,608.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,657 | |
| Funding Only Action | $6,657 | |
| Original award | $3,804 |
About this award
Lonza Walkersville, Inc. received a contract award on October 21, 2014, valued at $7,608 under a Blanket Purchase Agreement (BPA) call for drugs and biologicals. The firm fixed price contract, which was performed at Lonza's Walkersville, Maryland facility, represents a task order against the company's larger $10 million single-award BPA with the Department of Health and Human Services Office of Logistics and Acquisition Operations, valid through December 31, 2025. No set-aside designation was applied to this procurement, indicating open competition. The contract was funded by the HHS Office of the Director, a civilian federal agency.
Lonza Walkersville, Inc., a foreign-owned subsidiary of the global Lonza Group, specializes in providing high-precision biological research products and scientific services to federal agencies. The company has established itself as a critical supplier to the National Institutes of Health and its various institutes, including the National Cancer Institute and National Institute of Allergy and Infectious Diseases, delivering specialized research equipment such as cell culture media, cell lines, transfection devices, and laboratory instrumentation. This task order completes by December 31, 2014, and represents one of numerous awards the company has received supporting research initiatives in cancer studies, infectious diseases, regenerative medicine, and cellular engineering across the federal research enterprise.
Quick answers
Who was awarded contract HHSN26300442?
HHSN26300442 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on October 21, 2014.
How much is contract HHSN26300442 worth?
The government has obligated $3,804 on HHSN26300442. Its potential value, with all options, is $7,608.
Is contract HHSN26300442 an order under another contract?
Yes. HHSN26300442 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300442 competed?
The extent of competition for HHSN26300442 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award